Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
ML
Milestone Scientific, Inc. Common Stock
MLSS
Volume
42.43K
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
ML
MLSS
ML
Milestone Scientific, Inc. Common Stock
MLSS
News
·
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
Mkt Cap
$29.6M
Volume
42.43K
Next Earnings
November 12th
Chart
Financials
Earnings
News
About
Insider
Filings
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call
Milestone Scientific Inc. (NYSE: MLSS), a developer of computerized drug delivery instruments, announced it will host a conference call on August 14, 2026, at 8:30 AM ET to discuss Q2 2026 financial results and corporate progress. The call will be available via telephone and webcast.
GlobeNewswire Inc. · Aug 6, 2026
Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025
Milestone Scientific reported stable Q3 2025 revenues of $2.4 million, reduced operating expenses by over $500,000, and continued advancing its dental and medical segment strategies with focus on cost management and growth initiatives.
GlobeNewswire Inc. · Nov 13, 2025
Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
Milestone Scientific Inc. has appointed Shanth Thiyagalingam, a seasoned MedTech executive, to its Board of Directors. Thiyagalingam brings extensive experience in commercial leadership, reimbursement strategy, and global market insights, which will support Milestone's growth across medical and dental segments.
GlobeNewswire Inc. · May 19, 2025
Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
Milestone Scientific announced the commercial rollout of its CompuFlo® Epidural System at Advanced Spine and Pain Management, following a successful pilot program. The company also reported increasing adoption of the system after a Medicare price assignment, highlighting its clinical and economic benefits.
GlobeNewswire Inc. · Jan 23, 2025
Milestone Scientific to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
Milestone Scientific Inc., a medical technology company, announced that its CEO and Chairman will be presenting at The Benchmark Company's investor conference on December 11th, 2024. The conference offers emerging growth companies access to institutional and individual investors in a one-on-one format.
GlobeNewswire Inc. · Dec 4, 2024
EXCLUSIVE: Milestone Scientific Announces Medicare Price Assignment For CompuFlo Epidural System For Back Pain Covering Additional US States - Benzinga
Milestone Scientific's CompuFlo Epidural System has received Medicare price assignment in additional US states, representing a significant addressable market for the company's technology.
Benzinga · Jul 23, 2024
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil
Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain
GlobeNewswire Inc. · Jun 18, 2024
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024
Sales through new online portal increase 31% over the same period last year
GlobeNewswire Inc. · May 16, 2024
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference Call
ROSELAND, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 16th, 2024, to discuss the company’s financial results for the first quarter ended March 31, 2024, as well as the company’s corporate progress and other developments.
GlobeNewswire Inc. · May 13, 2024
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within PRC Alliance Pain Relief Center in Ormond Beach, Florida
PRC Alliance Pain Relief Center operates 8 locations across central Florida
GlobeNewswire Inc. · Apr 3, 2024
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
ML
MLSS
Milestone Scientific, Inc. Common Stock
Buy
Sell
Market
Limit
Soon
MLSS
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any MLSS yet.
Related Tickers
Earnings